To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
936 Current news
rss
matching the following criteria
Scientists decode genome of deadly parasitic worm
21-07-2009
Scientists have sequenced the genome of the parasite that causes intestinal schistosomiasis (also known as bilharzia or snail fever), a devastating tropical disease that afflicts more than 200 million people in the developing world. Najib El-Sayed, associate professor in the University of ...
Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
17-07-2009
Shire plc announces it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for velaglucerase alfa, its enzyme replacement therapy in development for the treatment of Type I Gaucher disease. Shire is working with the FDA to determine subsequent steps and timing ...
Medical use for waste television screens
16-07-2009
Waste material from discarded televisions could be recycled and used in medicine, according to new research by scientists at the University of York. The chemical compound polyvinyl-alcohol (PVA) is widely used in industry and is a key element of television sets with liquid crystal display ...
Intertek Strengthens European Analytical Laboratory Capabilities in the UK
15-07-2009
Intertek is strengthening its technical capabilities in the UK by merging two key facilities, creating a European Analytical Testing Centre of Excellence in Manchester. The resources and expertise of Intertek’s North West Technology Centre (NWTC) at Bebington and the Analytical Sciences ...
Biogen Idec Receives Fast Track Designation from FDA for PEGylated Interferon Beta-1a for Relapsing Multiple Sclerosis
13-07-2009
Biogen Idec announced the U.S. Food and Drug Administration (FDA) has granted PEGylated interferon beta-1a (BIIB017) Fast Track designation for relapsing multiple sclerosis (RMS). Biogen Idec is currently enrolling patients in a global Phase III study evaluating the efficacy and safety of ...
Human sperm created from embryonic stem cells
13-07-2009
Human sperm have been created using embryonic stem cells for the first time in a scientific development which will lead researchers to a better understanding of the causes of infertility. Researchers led by Professor Karim Nayernia at Newcastle University and the NorthEast England Stem Cell ...
Funxional successfully completes initial clinical trial of FX125L, an anti-inflammatory drug with a novel mechanism of action
10-07-2009
Funxional Therapeutics Ltd has announced the successful completion of the first Phase I study with FX125L, an orally available small molecule which belongs to a new therapeutic class named Broad Spectrum Chemokine Inhibitors (BSCIs). The Phase I, single ascending dose study was conducted in ...
Lord Drayson inaugurates new Oxford Nanopore facility at The Oxford Science Park
10-07-2009
Oxford Nanopore Technology’s new building was officially opened by Science and Innovation Minister Lord Drayson. The Science Minister visited the new home for the Oxford-based technology company at the Oxford Science Park. The company, founded in 2005, now employs 60 people and its new home ...
Quotient Clinical Receives MHRA Supplementary Accreditation
08-07-2009
Quotient Clinical announces that it has been awarded Supplementary Accreditation from the Medicines and Healthcare products Regulatory Agency (MHRA). This is one of the highest levels of accreditation in Europe and confirms that Quotient Clinical is qualified to perform the full range of ...
Frost & Sullivan Identifies Innovative and Cost-effective Technology as Key Competitive Factor in European Medical Device Market
08-07-2009
The medical device industry is one of the most vital and dynamic sectors of the European economy. The industry is constantly driven by R&D, which needs to keep pace with the evolving demands of the medical fraternity. New analysis from Frost & Sullivan, European Medical Device Company ...
Netmeeting
